View Financial HealthRealco 配当と自社株買い配当金 基準チェック /06Realco現在配当金を支払っていません。主要情報0%配当利回りn/aバイバック利回り総株主利回りn/a将来の配当利回りn/a配当成長n/a次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向0%最近の配当と自社株買いの更新更新なしすべての更新を表示Recent updatesBoard Change • 9hNo independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 7 non-independent directors. Director Aline Le Clef was the last director to join the board, commencing their role in 2024. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.Valuation Update With 7 Day Price Move • Feb 24Investor sentiment improves as stock rises 19%After last week's 19% share price gain to €17.90, the stock trades at a trailing P/E ratio of 73.5x. Average trailing P/E is 18x in the Chemicals industry in Europe. Total loss to shareholders of 15% over the past three years.Valuation Update With 7 Day Price Move • Feb 06Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to €16.20, the stock trades at a trailing P/E ratio of 66.6x. Average trailing P/E is 19x in the Chemicals industry in Europe. Total loss to shareholders of 23% over the past three years.Valuation Update With 7 Day Price Move • Dec 10Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to €17.50, the stock trades at a trailing P/E ratio of 71.9x. Average trailing P/E is 17x in the Chemicals industry in Europe. Total loss to shareholders of 17% over the past three years.New Risk • Nov 30New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.7x net interest cover). Share price has been highly volatile over the past 3 months (16% average weekly change). Earnings have declined by 28% per year over the past 5 years. Market cap is less than US$10m (€7.40m market cap, or US$8.59m). Minor Risks Latest financial reports are more than 6 months old (reported December 2024 fiscal period end). Profit margins are more than 30% lower than last year (1.3% net profit margin).New Risk • Nov 25New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €7.34m (US$8.48m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.7x net interest cover). Share price has been highly volatile over the past 3 months (16% average weekly change). Earnings have declined by 28% per year over the past 5 years. Market cap is less than US$10m (€7.34m market cap, or US$8.48m). Minor Risk Profit margins are more than 30% lower than last year (1.3% net profit margin).分析記事 • Nov 12Subdued Growth No Barrier To Realco SA (EBR:REAL) With Shares Advancing 32%The Realco SA ( EBR:REAL ) share price has done very well over the last month, posting an excellent gain of 32%. The...分析記事 • Nov 12Subdued Growth No Barrier To Realco SA (EBR:REAL) With Shares Advancing 32%The Realco SA ( EBR:REAL ) share price has done very well over the last month, posting an excellent gain of 32%. The...Board Change • Oct 31No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 2 highly experienced directors. No independent directors (7 non-independent directors). Director Frederic Tiberghien was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Board Change • Sep 29No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 2 highly experienced directors. No independent directors (7 non-independent directors). Director Frederic Tiberghien was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Board Change • Aug 08No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 2 highly experienced directors. No independent directors (7 non-independent directors). Director Frederic Tiberghien was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.分析記事 • Jun 20Realco (EBR:REAL) Seems To Be Using A Lot Of DebtDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...New Risk • Jun 19New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Belgian stocks, typically moving 2.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.7x net interest cover). Earnings have declined by 28% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (2.0% average weekly change). Profit margins are more than 30% lower than last year (1.3% net profit margin). Market cap is less than US$100m (€7.98m market cap, or US$9.16m).Board Change • Jun 19No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 2 highly experienced directors. No independent directors (7 non-independent directors). Director Frederic Tiberghien was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Reported Earnings • May 19Full year 2024 earnings releasedFull year 2024 results: Revenue: €13.4m (up 14% from FY 2023). Net income: €156.7k (down 40% from FY 2023). Profit margin: 1.2% (down from 2.2% in FY 2023). The decrease in margin was driven by higher expenses.Board Change • May 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 2 highly experienced directors. No independent directors (7 non-independent directors). Director Frederic Tiberghien was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.New Risk • Mar 20New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €8.50m (US$9.26m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.6% average weekly change). Market cap is less than US$10m (€8.50m market cap, or US$9.26m). Minor Risks High level of debt (57% net debt to equity). Latest financial reports are more than 6 months old (reported December 2023 fiscal period end). Large one-off items impacting financial results.Board Change • Mar 19No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 2 highly experienced directors. No independent directors (7 non-independent directors). Director Frederic Tiberghien was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Valuation Update With 7 Day Price Move • Feb 19Investor sentiment deteriorates as stock falls 21%After last week's 21% share price decline to €15.00, the stock trades at a trailing P/E ratio of 37.2x. Average trailing P/E is 19x in the Chemicals industry in Europe. Total loss to shareholders of 21% over the past three years.Board Change • Feb 19No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 2 highly experienced directors. No independent directors (7 non-independent directors). Director Frederic Tiberghien was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.New Risk • Jan 24New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Belgian stocks, typically moving 4.4% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (4.4% average weekly change). Minor Risks High level of debt (57% net debt to equity). Latest financial reports are more than 6 months old (reported December 2023 fiscal period end). Large one-off items impacting financial results. Market cap is less than US$100m (€9.98m market cap, or US$10.5m).Valuation Update With 7 Day Price Move • Jan 24Investor sentiment improves as stock rises 23%After last week's 23% share price gain to €19.00, the stock trades at a trailing P/E ratio of 47.1x. Average trailing P/E is 18x in the Chemicals industry in Europe. Total loss to shareholders of 3.1% over the past three years.Board Change • Jan 24No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 2 highly experienced directors. No independent directors (7 non-independent directors). Director Frederic Tiberghien was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.New Risk • Nov 29New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 1.0% per year over the past 5 years. Market cap is less than US$10m (€8.62m market cap, or US$9.11m). Minor Risks High level of debt (57% net debt to equity). Latest financial reports are more than 6 months old (reported December 2023 fiscal period end). Large one-off items impacting financial results.New Risk • Oct 29New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €9.01m (US$9.74m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 1.0% per year over the past 5 years. Market cap is less than US$10m (€9.01m market cap, or US$9.74m). Minor Risks High level of debt (57% net debt to equity). Large one-off items impacting financial results.Reported Earnings • May 13Full year 2023 earnings releasedFull year 2023 results: Revenue: €12.7m (up 31% from FY 2022). Net income: €259.4k (up 110% from FY 2022). Profit margin: 2.0% (up from 1.3% in FY 2022).New Risk • Apr 02New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €9.28m (US$9.97m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Revenue has declined by 29% over the past year. Market cap is less than US$10m (€9.28m market cap, or US$9.97m). Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1.3% net profit margin).New Risk • Dec 31New major risk - Revenue and earnings growthRevenue has declined by 29% over the past year. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If revenues are declining, then it is difficult for the company to prevent its earnings from declining as well. A trend of falling revenue can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Revenue has declined by 29% over the past year. Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1.3% net profit margin). Market cap is less than US$100m (€11.8m market cap, or US$13.0m).New Risk • Jul 27New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Over 987x increase in shares outstanding. This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported December 2021 fiscal period end). Shares are highly illiquid. Shareholders have been substantially diluted in the past year (over 987x increase in shares outstanding). Minor Risk Market cap is less than US$100m (€12.7m market cap, or US$14.0m).Board Change • Jun 14No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 8 non-independent directors. Director Frederic Tiberghien was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • May 17No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 8 non-independent directors. Director Frederic Tiberghien was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • Apr 28No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 8 non-independent directors. Director Frederic Tiberghien was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • Mar 24No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 8 non-independent directors. Director Frederic Tiberghien was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • Jan 18No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 8 non-independent directors. Director Frederic Tiberghien was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • Nov 30No independent directorsThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 4 experienced directors. 2 highly experienced directors. No independent directors (7 non-independent directors). Director Thierry Levintoff was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Board Change • Aug 31No independent directorsThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 4 experienced directors. 2 highly experienced directors. No independent directors (7 non-independent directors). Director Thierry Levintoff was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Board Change • Jul 25No independent directorsThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 4 experienced directors. 2 highly experienced directors. No independent directors (7 non-independent directors). Director Thierry Levintoff was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Board Change • Jun 20No independent directorsThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 4 experienced directors. 2 highly experienced directors. No independent directors (7 non-independent directors). Director Thierry Levintoff was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Board Change • May 04No independent directorsThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 4 experienced directors. 2 highly experienced directors. No independent directors (7 non-independent directors). Director Thierry Levintoff was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Board Change • Feb 24No independent directorsThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 4 experienced directors. 2 highly experienced directors. No independent directors (7 non-independent directors). Director Thierry Levintoff was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Valuation Update With 7 Day Price Move • Dec 10Investor sentiment improved over the past weekAfter last week's 24% share price gain to €18.30, the stock trades at a trailing P/E ratio of 6.1x. Average trailing P/E is 15x in the Chemicals industry in Belgium. Total loss to shareholders of 12% over the past three years.Board Change • Sep 10No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 9 non-independent directors. Director Thierry Levintoff was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.決済の安定と成長配当データの取得安定した配当: REALの 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。増加する配当: REALの配当金が増加しているかどうかを判断するにはデータが不十分です。配当利回り対市場Realco 配当利回り対市場REAL 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (REAL)0%市場下位25% (BE)2.4%市場トップ25% (BE)6.5%業界平均 (Chemicals)4.0%アナリスト予想 (REAL) (最長3年)n/a注目すべき配当: REALは最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。高配当: REALは最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。株主への利益配当収益カバレッジ: REAL Belgian市場において目立った配当金を支払っていません。株主配当金キャッシュフローカバレッジ: REALが配当金を報告していないため、配当金の持続可能性を計算できません。高配当企業の発掘7D1Y7D1Y7D1YBE 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/20 05:49終値2026/05/20 00:00収益2024/12/31年間収益2024/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Realco SA 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Board Change • 9hNo independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 7 non-independent directors. Director Aline Le Clef was the last director to join the board, commencing their role in 2024. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
Valuation Update With 7 Day Price Move • Feb 24Investor sentiment improves as stock rises 19%After last week's 19% share price gain to €17.90, the stock trades at a trailing P/E ratio of 73.5x. Average trailing P/E is 18x in the Chemicals industry in Europe. Total loss to shareholders of 15% over the past three years.
Valuation Update With 7 Day Price Move • Feb 06Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to €16.20, the stock trades at a trailing P/E ratio of 66.6x. Average trailing P/E is 19x in the Chemicals industry in Europe. Total loss to shareholders of 23% over the past three years.
Valuation Update With 7 Day Price Move • Dec 10Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to €17.50, the stock trades at a trailing P/E ratio of 71.9x. Average trailing P/E is 17x in the Chemicals industry in Europe. Total loss to shareholders of 17% over the past three years.
New Risk • Nov 30New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.7x net interest cover). Share price has been highly volatile over the past 3 months (16% average weekly change). Earnings have declined by 28% per year over the past 5 years. Market cap is less than US$10m (€7.40m market cap, or US$8.59m). Minor Risks Latest financial reports are more than 6 months old (reported December 2024 fiscal period end). Profit margins are more than 30% lower than last year (1.3% net profit margin).
New Risk • Nov 25New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €7.34m (US$8.48m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.7x net interest cover). Share price has been highly volatile over the past 3 months (16% average weekly change). Earnings have declined by 28% per year over the past 5 years. Market cap is less than US$10m (€7.34m market cap, or US$8.48m). Minor Risk Profit margins are more than 30% lower than last year (1.3% net profit margin).
分析記事 • Nov 12Subdued Growth No Barrier To Realco SA (EBR:REAL) With Shares Advancing 32%The Realco SA ( EBR:REAL ) share price has done very well over the last month, posting an excellent gain of 32%. The...
分析記事 • Nov 12Subdued Growth No Barrier To Realco SA (EBR:REAL) With Shares Advancing 32%The Realco SA ( EBR:REAL ) share price has done very well over the last month, posting an excellent gain of 32%. The...
Board Change • Oct 31No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 2 highly experienced directors. No independent directors (7 non-independent directors). Director Frederic Tiberghien was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Board Change • Sep 29No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 2 highly experienced directors. No independent directors (7 non-independent directors). Director Frederic Tiberghien was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Board Change • Aug 08No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 2 highly experienced directors. No independent directors (7 non-independent directors). Director Frederic Tiberghien was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
分析記事 • Jun 20Realco (EBR:REAL) Seems To Be Using A Lot Of DebtDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
New Risk • Jun 19New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Belgian stocks, typically moving 2.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.7x net interest cover). Earnings have declined by 28% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (2.0% average weekly change). Profit margins are more than 30% lower than last year (1.3% net profit margin). Market cap is less than US$100m (€7.98m market cap, or US$9.16m).
Board Change • Jun 19No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 2 highly experienced directors. No independent directors (7 non-independent directors). Director Frederic Tiberghien was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Reported Earnings • May 19Full year 2024 earnings releasedFull year 2024 results: Revenue: €13.4m (up 14% from FY 2023). Net income: €156.7k (down 40% from FY 2023). Profit margin: 1.2% (down from 2.2% in FY 2023). The decrease in margin was driven by higher expenses.
Board Change • May 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 2 highly experienced directors. No independent directors (7 non-independent directors). Director Frederic Tiberghien was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
New Risk • Mar 20New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €8.50m (US$9.26m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.6% average weekly change). Market cap is less than US$10m (€8.50m market cap, or US$9.26m). Minor Risks High level of debt (57% net debt to equity). Latest financial reports are more than 6 months old (reported December 2023 fiscal period end). Large one-off items impacting financial results.
Board Change • Mar 19No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 2 highly experienced directors. No independent directors (7 non-independent directors). Director Frederic Tiberghien was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Valuation Update With 7 Day Price Move • Feb 19Investor sentiment deteriorates as stock falls 21%After last week's 21% share price decline to €15.00, the stock trades at a trailing P/E ratio of 37.2x. Average trailing P/E is 19x in the Chemicals industry in Europe. Total loss to shareholders of 21% over the past three years.
Board Change • Feb 19No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 2 highly experienced directors. No independent directors (7 non-independent directors). Director Frederic Tiberghien was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
New Risk • Jan 24New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Belgian stocks, typically moving 4.4% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (4.4% average weekly change). Minor Risks High level of debt (57% net debt to equity). Latest financial reports are more than 6 months old (reported December 2023 fiscal period end). Large one-off items impacting financial results. Market cap is less than US$100m (€9.98m market cap, or US$10.5m).
Valuation Update With 7 Day Price Move • Jan 24Investor sentiment improves as stock rises 23%After last week's 23% share price gain to €19.00, the stock trades at a trailing P/E ratio of 47.1x. Average trailing P/E is 18x in the Chemicals industry in Europe. Total loss to shareholders of 3.1% over the past three years.
Board Change • Jan 24No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 2 highly experienced directors. No independent directors (7 non-independent directors). Director Frederic Tiberghien was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
New Risk • Nov 29New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 1.0% per year over the past 5 years. Market cap is less than US$10m (€8.62m market cap, or US$9.11m). Minor Risks High level of debt (57% net debt to equity). Latest financial reports are more than 6 months old (reported December 2023 fiscal period end). Large one-off items impacting financial results.
New Risk • Oct 29New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €9.01m (US$9.74m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 1.0% per year over the past 5 years. Market cap is less than US$10m (€9.01m market cap, or US$9.74m). Minor Risks High level of debt (57% net debt to equity). Large one-off items impacting financial results.
Reported Earnings • May 13Full year 2023 earnings releasedFull year 2023 results: Revenue: €12.7m (up 31% from FY 2022). Net income: €259.4k (up 110% from FY 2022). Profit margin: 2.0% (up from 1.3% in FY 2022).
New Risk • Apr 02New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €9.28m (US$9.97m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Revenue has declined by 29% over the past year. Market cap is less than US$10m (€9.28m market cap, or US$9.97m). Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1.3% net profit margin).
New Risk • Dec 31New major risk - Revenue and earnings growthRevenue has declined by 29% over the past year. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If revenues are declining, then it is difficult for the company to prevent its earnings from declining as well. A trend of falling revenue can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Revenue has declined by 29% over the past year. Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1.3% net profit margin). Market cap is less than US$100m (€11.8m market cap, or US$13.0m).
New Risk • Jul 27New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Over 987x increase in shares outstanding. This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported December 2021 fiscal period end). Shares are highly illiquid. Shareholders have been substantially diluted in the past year (over 987x increase in shares outstanding). Minor Risk Market cap is less than US$100m (€12.7m market cap, or US$14.0m).
Board Change • Jun 14No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 8 non-independent directors. Director Frederic Tiberghien was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • May 17No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 8 non-independent directors. Director Frederic Tiberghien was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • Apr 28No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 8 non-independent directors. Director Frederic Tiberghien was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • Mar 24No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 8 non-independent directors. Director Frederic Tiberghien was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • Jan 18No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 8 non-independent directors. Director Frederic Tiberghien was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • Nov 30No independent directorsThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 4 experienced directors. 2 highly experienced directors. No independent directors (7 non-independent directors). Director Thierry Levintoff was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Board Change • Aug 31No independent directorsThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 4 experienced directors. 2 highly experienced directors. No independent directors (7 non-independent directors). Director Thierry Levintoff was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Board Change • Jul 25No independent directorsThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 4 experienced directors. 2 highly experienced directors. No independent directors (7 non-independent directors). Director Thierry Levintoff was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Board Change • Jun 20No independent directorsThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 4 experienced directors. 2 highly experienced directors. No independent directors (7 non-independent directors). Director Thierry Levintoff was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Board Change • May 04No independent directorsThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 4 experienced directors. 2 highly experienced directors. No independent directors (7 non-independent directors). Director Thierry Levintoff was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Board Change • Feb 24No independent directorsThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 4 experienced directors. 2 highly experienced directors. No independent directors (7 non-independent directors). Director Thierry Levintoff was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Valuation Update With 7 Day Price Move • Dec 10Investor sentiment improved over the past weekAfter last week's 24% share price gain to €18.30, the stock trades at a trailing P/E ratio of 6.1x. Average trailing P/E is 15x in the Chemicals industry in Belgium. Total loss to shareholders of 12% over the past three years.
Board Change • Sep 10No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 9 non-independent directors. Director Thierry Levintoff was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.